06:01:04 Europe / Stockholm

Prenumeration

2022-11-11 07:21:00

Redeye comments on Cantargia's third quarter report and events after the end of the quarter, including the decision to pause three trials.

Read more and download the Research Update.

Follow companies at Redeye to receive the latest equity research within Life Science and Technology.

This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/